Fri, Jan 30, 2015, 5:34 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Shire plc Message Board

  • blackoutbuzz blackoutbuzz Nov 22, 2011 9:10 PM Flag

    SHPGY expands US operations

    Looks like business is going well in rare diseases.

    LEXINGTON, Massachusetts, November 22, 2011 /PRNewswire/ --
    Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that it has submitted regulatory filings with both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) for the production of VPRIV® (velaglucerase alfa) in its state-of-the-art manufacturing facility at 400 Shire Way in Lexington, Massachusetts. Subject to regulatory approval, which is anticipated in early 2012, Shire expects the new plant to significantly increase manufacturing capacity and allow for increased global supply of VPRIV. These approvals will also make available further capacity for the manufacture of Replagal® (agalsidase alfa) at Shire's Alewife facility, where both VPRIV and Replagal are currently manufactured.

219.26-2.91(-1.31%)Jan 30 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.